Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VH4527079
- Development stage
- Phase 1
- Lead developer
- ViiV Healthcare
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous, Subcutaneous
01
Overview
VH4527079 is a human monoclonal antibody developed by ViiV Healthcare for the treatment of HIV infection. It is being investigated as a potential therapy for people living with HIV, with clinical trials evaluating its safety, tolerability, and pharmacokinetics in both healthy adults and individuals with well-controlled HIV. The drug is administered via intravenous or subcutaneous routes. While the precise mechanism of action has not been disclosed publicly as of April 2025, it is described as an antibody modality and may be bi-specific based on preclinical pipeline information from ViiV Healthcare. The highest development phase reported for this agent in HIV infections is Phase 1.
- Other names
- VH-4527079VH4527079VH 4527079VH-079VH079VH 079
02
Targets
Env (HIV-1 envelope glycoprotein)
Beyond the preview
Go deeper on VH4527079.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VH4527079.